Published in J Infect Dis on April 01, 1978
Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff. J Hyg (Lond) (1982) 1.32
Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination. Am J Public Health (1985) 1.25
Geographic location of commercial plasma donation clinics in the United States, 1980-1995. Am J Public Health (2004) 1.03
Cost without benefit? The introduction of hepatitis B vaccine in Canada. Can Med Assoc J (1983) 0.89
Prevalence of markers for hepatitis B and hepatitis D in a municipal house of correction. Am J Public Health (1990) 0.81
Should prisoners be immunized against hepatitis B? Am J Public Health (1985) 0.75
Heterogeneity in hepatitis B virus (HBV) seroprevalence estimates from U.S. adult incarcerated populations. Ann Epidemiol (2009) 0.75
The continuing epidemics of obesity and diabetes in the United States. JAMA (2001) 14.84
The spread of the obesity epidemic in the United States, 1991-1998. JAMA (1999) 11.52
Health literacy among Medicare enrollees in a managed care organization. JAMA (1999) 8.63
Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Intern Med (1998) 7.26
Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques (2000) 7.03
Health reform and the health of the public. Forging community health partnerships. JAMA (1994) 6.18
The relationship between method of physician payment and patient trust. JAMA (1998) 5.56
Effects of parietal injury on covert orienting of attention. J Neurosci (1984) 5.26
Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect Immun (1987) 4.92
Use of laminar air-flow equipment in microbiology. Appl Microbiol (1968) 3.79
Patients' trust in their physicians: effects of choice, continuity, and payment method. J Gen Intern Med (1998) 3.51
Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J Epidemiol (1979) 3.36
Nucleotide sequence of the streptolysin O (SLO) gene: structural homologies between SLO and other membrane-damaging, thiol-activated toxins. Infect Immun (1987) 3.24
Hepatitis B infection in physicians. Results of a nationwide seroepidemiologic survey. JAMA (1978) 3.24
Internists' practices in health promotion and disease prevention. A survey. Ann Intern Med (1991) 3.00
Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis (1982) 2.96
Caloric imbalance and public health policy. JAMA (1999) 2.92
Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80
The continuing epidemic of obesity in the United States. JAMA (2000) 2.80
Oyster-associated hepatitis. Failure of shellfish certification programs to prevent outbreaks. JAMA (1975) 2.71
Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health (1985) 2.58
A cost-effectiveness analysis of exercise as a health promotion activity. Am J Public Health (1988) 2.46
Barriers to using cost-effectiveness analysis in managed care decision making. Am J Manag Care (2000) 2.41
Genetic dissection of the photoreceptor system in the compound eye of Drosophila melanogaster. J Physiol (1976) 2.28
Smaug, a novel RNA-binding protein that operates a translational switch in Drosophila. Mol Cell (1999) 2.21
Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy. JAMA (1986) 2.18
Detection by radioimmunoassay of antibodies in human smallpox patients and vaccinees. J Clin Microbiol (1975) 2.01
Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol (1998) 1.95
Expression of the pneumolysin gene in Escherichia coli: rapid purification and biological properties. Biochim Biophys Acta (1989) 1.94
Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity. Infect Immun (1989) 1.91
Comparative evaluation of biochemical and microscopic urinalysis. Am J Med Technol (1983) 1.89
A cost-benefit/cost-effectiveness analysis of smoking cessation for pregnant women. Am J Prev Med (1991) 1.84
Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine. Ann Intern Med (1987) 1.80
An epidemiologic study of the benefits and risks of running. JAMA (1982) 1.76
Pertussis vaccine--an analysis of benefits, risks and costs. N Engl J Med (1979) 1.75
Choice of preventive treatment for isoniazid-resistant tuberculous infection. Use of decision analysis and the Delphi technique. JAMA (1980) 1.74
Cigarette smoking in China. Prevalence, characteristics, and attitudes in Minhang District. JAMA (1995) 1.72
The economic impact of viral hepatitis in the United States. Public Health Rep (1976) 1.67
Length-of-stay after delivery: managed care versus fee-for-service. Health Aff (Millwood) (1996) 1.67
A TMS coil positioning/holding system for MR image-guided TMS interleaved with fMRI. Clin Neurophysiol (2003) 1.62
Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy. Arch Pathol Lab Med (1997) 1.61
Preventing neonatal herpes. The value of weekly viral cultures in pregnant women with recurrent genital herpes. JAMA (1984) 1.59
Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs. JAMA (1984) 1.59
Hepatitis B antigens in serum and liver of chimpanzees acutely infected with hepatitis B virus. Infect Immun (1975) 1.59
Letter: Infectivity of serum containing HBsAg and antibody to e antigen. Lancet (1976) 1.56
Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis (1975) 1.55
Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics (1975) 1.55
Hippocampal connections and spatial discrimination. Brain Res (1978) 1.54
Corpus callosotomy: a quantitative study of the extent of resection, seizure control, and neuropsychological outcome. J Neurosurg (1993) 1.54
How do the parietal lobes direct covert attention? Neuropsychologia (1987) 1.51
An outbreak of hepatitis-A associated with recreational lake water. Am J Epidemiol (1974) 1.51
The risks of exercise: a public health view of injuries and hazards. Public Health Rep (1985) 1.50
Serological and epidemiological studies of hepatitis B in haemodialysis units. Lancet (1973) 1.49
Lipid screening in a managed care population. Public Health Rep (1998) 1.49
Limitations of Wada memory asymmetry as a predictor of outcomes after temporal lobectomy. Neurology (2005) 1.47
Comparable safety of blood collection in "high-risk" autologous donors versus non-high-risk autologous and directed donors in a hospital setting. Am J Clin Pathol (1994) 1.42
The Holy Cross college football team hepatitis outbreak. JAMA (1972) 1.42
Viral hepatitis, type B, in experimental animals. Am J Med Sci (1976) 1.41
Nutrient intake and supplementation in the United States (NHANES II). Am J Public Health (1986) 1.41
Food safety considerations. J Am Vet Med Assoc (1995) 1.39
Epidemiology of hepatitis B in two Alaska communities. Am J Epidemiol (1977) 1.34
Nanotechnology and water treatment: applications and emerging opportunities. Crit Rev Microbiol (2008) 1.34
Endomyocardial fibrosis. A surgical approach. Ann Thorac Surg (1974) 1.33
Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl Environ Microbiol (1976) 1.30
Chronic disease in the 1990s. Annu Rev Public Health (1990) 1.27
Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease. Brain (1984) 1.27
Pertussis and pertussis vaccine: further analysis of benefits, risks and costs. Dev Biol Stand (1985) 1.26
Value of stool cultures. Lancet (1980) 1.26
The cell biology of bone metabolism. J Clin Pathol (2008) 1.26
Assessment of susceptibility to measles and rubella. JAMA (1982) 1.26
Evaluation of a finger prick blood collection method for the seroepidemiology of hepatitis B. Bull World Health Organ (1978) 1.25
A benefit-cost analysis of a childhood varicella vaccination programme. Postgrad Med J (1985) 1.24
Physician incentives and disclosure of payment methods to patients. J Gen Intern Med (2001) 1.23
Hepatitis B in an oncology unit. N Engl J Med (1974) 1.23
The case for global measles eradication. Lancet (1982) 1.23
Vitamin and mineral supplement use and mortality in a US cohort. Am J Public Health (1993) 1.18
Lipid requirement of the membrane sodium-plus-potassium ion-dependent adenosine triphosphatase system. Biochem J (1975) 1.18
Detection methods for study of the stability of hepatitis B antigen on surfaces. J Infect Dis (1974) 1.16
A comprehensive expressed sequence tag linkage map for tiger salamander and Mexican axolotl: enabling gene mapping and comparative genomics in Ambystoma. Genetics (2005) 1.16
Hormonal changes throughout the menstrual cycle and increased anterior cruciate ligament laxity in females. J Athl Train (1999) 1.15
A disconnection analysis of hippocampal function. Brain Res (1982) 1.15
The epidemiologic field investigation: science and judgment in public health practice. Am J Epidemiol (1990) 1.14
New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. Bioconjug Chem (1999) 1.13
Factors associated with cognitive recovery after cardiopulmonary resuscitation. Am J Crit Care (1996) 1.12
Design, synthesis, and antiviral activity of alpha-nucleosides: D- and L-isomers of lyxofuranosyl- and (5-deoxylyxofuranosyl)benzimidazoles. J Med Chem (1998) 1.12
Relation of e antigen to hepatitis B virus infection in an area of hyperendemicity. J Infect Dis (1976) 1.12
The protective efficacy of immune serum globulin in hepatitis A: a statistical approach. JAMA (1973) 1.10
A benefit-cost analysis of mumps vaccine. Am J Dis Child (1982) 1.08
Letter: Hepatitis-B antigen on environmental surfaces. Lancet (1973) 1.07
Surveillance of arboviral encephalitis in the United States, 1955-1971. Am J Epidemiol (1973) 1.06
Immunization of asymptomatic HIV-infected children with measles vaccine: assessment of risks and benefits. Med Decis Making (1989) 1.06
Live or inactivated poliomyelitis vaccine: an analysis of benefits and risks. Am J Public Health (1988) 1.06
Neuroanatomical bases of spatial memory. Brain Res (1980) 1.05
Physical activity and chronic diseases. Am J Clin Nutr (1989) 1.05
Hemodialysis-associated hepatitis. JAMA (1973) 1.05
Vibrio carchariae infection after a shark bite. Ann Intern Med (1989) 1.05
Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis. Int J Epidemiol (1992) 1.03
Assessing prevention effectiveness using data to drive program decisions. Public Health Rep (1994) 1.03
Simultaneous infection with type A and B hepatitis viruses. Am J Epidemiol (1977) 1.03
Community participation in malaria surveillance and treatment. III. An evaluation of modifications in the Volunteer Collaborator Network of Guatemala. Am J Trop Med Hyg (1994) 1.02